- Type / Class
- Equity / Common Stock
- Shares outstanding
- 46,821,220
- Total 13F shares
- 9,293,451
- Share change
- -13,531
- Total reported value
- $46,466,940
- Price per share
- $5.00
- Number of holders
- 11
- Value change
- -$68,645
- Number of buys
- 3
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 63009J107?
CUSIP 63009J107 identifies NBTX - Nanobiotix S.A. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 63009J107:
Top shareholders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON |
13F
|
Company |
12%
|
5,623,816
|
$36,554,242 | — | 31 Mar 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
6.1%
|
2,869,030
|
$17,902,747 | — | 31 Mar 2024 | |
| Invus Global Management, LLC |
13D/G
|
Invus Public Equities, L.P. |
8.9%
|
4,232,829
|
$13,545,053 | $0 | 31 Dec 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
555,066
|
$3,607,873 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.54%
|
253,454
|
$1,647,426 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,100
|
$20,150 | — | 31 Mar 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
1,150
|
$7,475 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
619
|
$3,863 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
450
|
$2,925 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
262
|
$1,703 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
33
|
$205 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2
|
$13 | — | 31 Mar 2024 |
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q2 2024
As of 30 Jun 2024,
Nanobiotix S.A. - Common Stock (NBTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,293,451 shares.
The largest 10 holders included
JOHNSON & JOHNSON, BAILLIE GIFFORD & CO, PERCEPTIVE ADVISORS LLC, BlackRock Inc., UBS Group AG, GAMMA Investing LLC, BANK OF AMERICA CORP /DE/, Qube Research & Technologies Ltd, Royal Bank of Canada, and BARCLAYS PLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q2 2024 holders
11
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.